These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10899401)

  • 21. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.
    Sapp E; Penney J; Young A; Aronin N; Vonsattel JP; DiFiglia M
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):165-73. PubMed ID: 10029099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insoluble TATA-binding protein accumulation in Huntington's disease cortex.
    van Roon-Mom WM; Reid SJ; Jones AL; MacDonald ME; Faull RL; Snell RG
    Brain Res Mol Brain Res; 2002 Dec; 109(1-2):1-10. PubMed ID: 12531510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
    J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis.
    Sang TK; Li C; Liu W; Rodriguez A; Abrams JM; Zipursky SL; Jackson GR
    Hum Mol Genet; 2005 Feb; 14(3):357-72. PubMed ID: 15590702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.
    Crittenden JR; Dunn DE; Merali FI; Woodman B; Yim M; Borkowska AE; Frosch MP; Bates GP; Housman DE; Lo DC; Graybiel AM
    Hum Mol Genet; 2010 May; 19(9):1756-65. PubMed ID: 20147317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAG-1 associates with the polyglutamine-expanded huntingtin aggregates.
    Jana NR; Nukina N
    Neurosci Lett; 2005 Apr; 378(3):171-5. PubMed ID: 15781153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology.
    Maheshwari M; Shekhar S; Singh BK; Jamal I; Vatsa N; Kumar V; Sharma A; Jana NR
    Hum Mol Genet; 2014 Dec; 23(23):6235-45. PubMed ID: 25027318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington's Disease.
    Dasgupta S; Fishman MA; Mahallati H; Castro LM; Tashima AK; Ferro ES; Fricker LD
    PLoS One; 2015; 10(12):e0145333. PubMed ID: 26691307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
    Luthi-Carter R; Hanson SA; Strand AD; Bergstrom DA; Chun W; Peters NL; Woods AM; Chan EY; Kooperberg C; Krainc D; Young AB; Tapscott SJ; Olson JM
    Hum Mol Genet; 2002 Aug; 11(17):1911-26. PubMed ID: 12165554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.
    Furlong RA; Narain Y; Rankin J; Wyttenbach A; Rubinsztein DC
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):577-81. PubMed ID: 10698681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arfaptin 2 regulates the aggregation of mutant huntingtin protein.
    Peters PJ; Ning K; Palacios F; Boshans RL; Kazantsev A; Thompson LM; Woodman B; Bates GP; D'Souza-Schorey C
    Nat Cell Biol; 2002 Mar; 4(3):240-5. PubMed ID: 11854752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
    Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
    J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T; Hamby A; Massa SM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
    J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The early cellular pathology of Huntington's disease.
    Li XJ
    Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are there multiple pathways in the pathogenesis of Huntington's disease?
    Aronin N; Kim M; Laforet G; DiFiglia M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):995-1003. PubMed ID: 10434298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.